-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Lowers Price Target to $21

Benzinga·11/10/2026 11:45:56
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy and lowers the price target from $23 to $21.